Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neoplasms, Germ Cell and Embryonal | 60 | 2024 | 496 | 14.190 |
Why?
|
Testicular Neoplasms | 25 | 2024 | 808 | 5.510 |
Why?
|
Ovarian Neoplasms | 29 | 2024 | 4919 | 3.250 |
Why?
|
Teratoma | 9 | 2023 | 405 | 1.950 |
Why?
|
Breast Diseases | 7 | 2017 | 442 | 1.440 |
Why?
|
Adolescent Behavior | 14 | 2014 | 1188 | 1.110 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 16 | 2021 | 11886 | 1.080 |
Why?
|
Child | 130 | 2024 | 80960 | 1.070 |
Why?
|
alpha-Fetoproteins | 7 | 2021 | 229 | 1.020 |
Why?
|
Sex Cord-Gonadal Stromal Tumors | 4 | 2024 | 118 | 1.010 |
Why?
|
Adolescent | 133 | 2024 | 89244 | 0.980 |
Why?
|
Neoplasms | 31 | 2024 | 22389 | 0.880 |
Why?
|
Neoplasm Staging | 25 | 2023 | 11262 | 0.860 |
Why?
|
Ribonuclease III | 6 | 2024 | 271 | 0.860 |
Why?
|
Milk | 7 | 2015 | 438 | 0.840 |
Why?
|
DEAD-box RNA Helicases | 6 | 2024 | 385 | 0.800 |
Why?
|
Endodermal Sinus Tumor | 6 | 2021 | 53 | 0.800 |
Why?
|
Pulmonary Blastoma | 4 | 2024 | 43 | 0.700 |
Why?
|
Mediastinal Neoplasms | 3 | 2020 | 403 | 0.680 |
Why?
|
Sertoli-Leydig Cell Tumor | 5 | 2024 | 21 | 0.680 |
Why?
|
Neoplasms, Second Primary | 3 | 2017 | 1060 | 0.660 |
Why?
|
Cisplatin | 10 | 2023 | 1661 | 0.660 |
Why?
|
Neoplasm Recurrence, Local | 8 | 2023 | 9442 | 0.640 |
Why?
|
Disease-Free Survival | 12 | 2023 | 6856 | 0.640 |
Why?
|
Carboplatin | 5 | 2019 | 799 | 0.630 |
Why?
|
Beauty Culture | 4 | 2012 | 41 | 0.620 |
Why?
|
Gonadal Dysgenesis | 1 | 2017 | 28 | 0.600 |
Why?
|
Fluorocarbons | 1 | 2023 | 506 | 0.600 |
Why?
|
Registries | 13 | 2024 | 8384 | 0.600 |
Why?
|
Diet | 16 | 2015 | 8088 | 0.580 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2020 | 335 | 0.560 |
Why?
|
Sunscreening Agents | 3 | 2015 | 139 | 0.550 |
Why?
|
Female | 151 | 2024 | 397515 | 0.550 |
Why?
|
Sacrococcygeal Region | 1 | 2016 | 53 | 0.550 |
Why?
|
Sunburn | 3 | 2015 | 156 | 0.540 |
Why?
|
Health Behavior | 7 | 2019 | 2649 | 0.540 |
Why?
|
Humans | 213 | 2024 | 768970 | 0.530 |
Why?
|
Infant | 39 | 2024 | 36556 | 0.530 |
Why?
|
Child, Preschool | 39 | 2024 | 42683 | 0.520 |
Why?
|
Risk-Taking | 6 | 2016 | 1023 | 0.500 |
Why?
|
Food, Fortified | 3 | 2012 | 189 | 0.500 |
Why?
|
Infant, Newborn, Diseases | 1 | 2021 | 587 | 0.500 |
Why?
|
Sunlight | 2 | 2015 | 337 | 0.500 |
Why?
|
Coitus | 3 | 2008 | 133 | 0.490 |
Why?
|
Young Adult | 50 | 2024 | 60131 | 0.450 |
Why?
|
Menarche | 7 | 2015 | 538 | 0.450 |
Why?
|
Antineoplastic Agents | 8 | 2021 | 13698 | 0.450 |
Why?
|
Nut Hypersensitivity | 1 | 2014 | 33 | 0.450 |
Why?
|
Wilms Tumor | 2 | 2022 | 378 | 0.440 |
Why?
|
Vitamin D | 6 | 2015 | 3311 | 0.440 |
Why?
|
Infant, Newborn | 25 | 2023 | 26428 | 0.440 |
Why?
|
Medical Oncology | 7 | 2023 | 2350 | 0.430 |
Why?
|
Ultraviolet Rays | 4 | 2020 | 1104 | 0.420 |
Why?
|
Male | 106 | 2024 | 365203 | 0.420 |
Why?
|
Lymphatic Metastasis | 1 | 2020 | 2916 | 0.410 |
Why?
|
Sexuality | 3 | 2016 | 179 | 0.410 |
Why?
|
Hearing Loss, High-Frequency | 1 | 2012 | 11 | 0.410 |
Why?
|
Adult | 72 | 2024 | 223851 | 0.400 |
Why?
|
Pediatrics | 3 | 2016 | 3628 | 0.400 |
Why?
|
Dairy Products | 5 | 2019 | 490 | 0.390 |
Why?
|
Prognosis | 20 | 2024 | 30046 | 0.390 |
Why?
|
Nuts | 1 | 2014 | 264 | 0.380 |
Why?
|
International Cooperation | 2 | 2015 | 1436 | 0.380 |
Why?
|
Rare Diseases | 2 | 2014 | 631 | 0.380 |
Why?
|
Smoking | 13 | 2014 | 9094 | 0.380 |
Why?
|
Klinefelter Syndrome | 2 | 2023 | 48 | 0.370 |
Why?
|
Age Factors | 21 | 2024 | 18435 | 0.370 |
Why?
|
Australia | 6 | 2024 | 1265 | 0.360 |
Why?
|
Carotenoids | 1 | 2014 | 620 | 0.360 |
Why?
|
Etoposide | 5 | 2017 | 639 | 0.360 |
Why?
|
Peanut Hypersensitivity | 1 | 2014 | 219 | 0.360 |
Why?
|
Vincristine | 5 | 2024 | 1040 | 0.350 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2014 | 395 | 0.350 |
Why?
|
Child Nutritional Physiological Phenomena | 5 | 2012 | 294 | 0.350 |
Why?
|
Drugs, Essential | 2 | 2021 | 71 | 0.350 |
Why?
|
Bleomycin | 4 | 2017 | 493 | 0.340 |
Why?
|
Adolescent Nutritional Physiological Phenomena | 6 | 2012 | 62 | 0.340 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2013 | 289 | 0.340 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 937 | 0.330 |
Why?
|
Dysgerminoma | 3 | 2018 | 66 | 0.330 |
Why?
|
Breast Neoplasms | 10 | 2015 | 21188 | 0.330 |
Why?
|
MicroRNAs | 5 | 2023 | 3811 | 0.320 |
Why?
|
Leukemia | 1 | 2017 | 1520 | 0.310 |
Why?
|
Seminoma | 3 | 2022 | 136 | 0.300 |
Why?
|
Nuclear Family | 1 | 2009 | 311 | 0.300 |
Why?
|
Mother-Child Relations | 2 | 2013 | 500 | 0.290 |
Why?
|
Mongolia | 6 | 2013 | 93 | 0.290 |
Why?
|
Germinoma | 3 | 2018 | 132 | 0.290 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2023 | 1560 | 0.290 |
Why?
|
Urban Population | 2 | 2013 | 2046 | 0.290 |
Why?
|
Child Health Services | 1 | 2013 | 645 | 0.280 |
Why?
|
Health Promotion | 4 | 2008 | 2210 | 0.280 |
Why?
|
Precancerous Conditions | 1 | 2014 | 985 | 0.280 |
Why?
|
Germ-Line Mutation | 4 | 2024 | 1887 | 0.280 |
Why?
|
Occupational Health Services | 2 | 2006 | 149 | 0.270 |
Why?
|
Meat | 2 | 2015 | 588 | 0.270 |
Why?
|
United States | 39 | 2024 | 73186 | 0.270 |
Why?
|
Incidence | 16 | 2024 | 21547 | 0.260 |
Why?
|
Intention | 1 | 2009 | 348 | 0.260 |
Why?
|
Cohort Studies | 30 | 2020 | 41808 | 0.260 |
Why?
|
Data Collection | 1 | 2014 | 3324 | 0.250 |
Why?
|
Health Priorities | 2 | 2019 | 380 | 0.250 |
Why?
|
Risk Factors | 28 | 2023 | 74976 | 0.250 |
Why?
|
Growth Hormone | 1 | 2007 | 573 | 0.240 |
Why?
|
Age Distribution | 6 | 2019 | 2875 | 0.240 |
Why?
|
Skin Neoplasms | 5 | 2020 | 5864 | 0.240 |
Why?
|
Nephrectomy | 1 | 2010 | 949 | 0.240 |
Why?
|
Longitudinal Studies | 21 | 2024 | 14794 | 0.240 |
Why?
|
Peripheral Nervous System Diseases | 2 | 2024 | 716 | 0.240 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 2 | 2017 | 71 | 0.230 |
Why?
|
Body Weight | 4 | 2011 | 4628 | 0.230 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7460 | 0.230 |
Why?
|
SEER Program | 4 | 2019 | 1473 | 0.230 |
Why?
|
Dietary Fats | 5 | 2010 | 2002 | 0.230 |
Why?
|
Social Control, Formal | 1 | 2004 | 107 | 0.230 |
Why?
|
Risk Reduction Behavior | 1 | 2011 | 1119 | 0.230 |
Why?
|
Chemotherapy, Adjuvant | 6 | 2024 | 3554 | 0.230 |
Why?
|
Workplace | 4 | 2006 | 873 | 0.230 |
Why?
|
Radionuclide Imaging | 2 | 2019 | 1998 | 0.220 |
Why?
|
Hearing Loss | 3 | 2021 | 785 | 0.220 |
Why?
|
Melanoma | 4 | 2017 | 5709 | 0.220 |
Why?
|
Body Image | 4 | 2004 | 646 | 0.220 |
Why?
|
Models, Statistical | 3 | 2019 | 5110 | 0.210 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2020 | 10400 | 0.210 |
Why?
|
Leisure Activities | 5 | 2008 | 310 | 0.210 |
Why?
|
Papillomavirus Vaccines | 1 | 2009 | 497 | 0.210 |
Why?
|
Mothers | 4 | 2013 | 2209 | 0.210 |
Why?
|
Dietary Supplements | 3 | 2013 | 3443 | 0.200 |
Why?
|
Retrospective Studies | 23 | 2023 | 81903 | 0.200 |
Why?
|
Taxes | 1 | 2004 | 220 | 0.200 |
Why?
|
Energy Intake | 7 | 2015 | 2146 | 0.200 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2013 | 2044 | 0.200 |
Why?
|
Exercise | 7 | 2008 | 5954 | 0.200 |
Why?
|
Canada | 2 | 2018 | 2130 | 0.190 |
Why?
|
Alcohol Drinking | 7 | 2015 | 4045 | 0.190 |
Why?
|
Fibrocystic Breast Disease | 2 | 2013 | 103 | 0.190 |
Why?
|
Libraries, Medical | 1 | 2021 | 12 | 0.190 |
Why?
|
Music Therapy | 1 | 2023 | 111 | 0.190 |
Why?
|
Vitamin E | 2 | 2004 | 874 | 0.190 |
Why?
|
Parenting | 1 | 2007 | 709 | 0.190 |
Why?
|
Developing Countries | 5 | 2020 | 2911 | 0.190 |
Why?
|
Rural Population | 1 | 2012 | 2325 | 0.190 |
Why?
|
Anthropometry | 3 | 2013 | 1345 | 0.180 |
Why?
|
Survivors | 3 | 2016 | 2383 | 0.180 |
Why?
|
Orchiectomy | 2 | 2020 | 468 | 0.180 |
Why?
|
Health Knowledge, Attitudes, Practice | 4 | 2013 | 4056 | 0.180 |
Why?
|
Neoplasm Invasiveness | 5 | 2023 | 3629 | 0.180 |
Why?
|
Prospective Studies | 19 | 2021 | 54962 | 0.170 |
Why?
|
Ovariectomy | 3 | 2019 | 613 | 0.170 |
Why?
|
Decision Support Techniques | 1 | 2010 | 2008 | 0.170 |
Why?
|
Music | 1 | 2023 | 247 | 0.170 |
Why?
|
Child Development | 3 | 2011 | 2336 | 0.170 |
Why?
|
Nurses | 2 | 2009 | 2501 | 0.170 |
Why?
|
Combined Modality Therapy | 4 | 2018 | 8559 | 0.170 |
Why?
|
Life Style | 5 | 2015 | 3931 | 0.170 |
Why?
|
Sunbathing | 1 | 2020 | 66 | 0.170 |
Why?
|
Clinical Trials as Topic | 5 | 2018 | 8055 | 0.160 |
Why?
|
Astrocytoma | 1 | 2024 | 781 | 0.160 |
Why?
|
Paclitaxel | 2 | 2024 | 1735 | 0.160 |
Why?
|
Clinical Trials, Phase III as Topic | 2 | 2020 | 878 | 0.160 |
Why?
|
Value of Life | 1 | 2019 | 98 | 0.160 |
Why?
|
Sex Factors | 10 | 2019 | 10633 | 0.160 |
Why?
|
Thiosulfates | 1 | 2018 | 52 | 0.150 |
Why?
|
Neuroblastoma | 2 | 2017 | 1266 | 0.150 |
Why?
|
Information Dissemination | 3 | 2022 | 1141 | 0.150 |
Why?
|
Guidelines as Topic | 2 | 2016 | 1399 | 0.150 |
Why?
|
Mental Recall | 4 | 2005 | 1226 | 0.150 |
Why?
|
Neoplasm, Residual | 2 | 2014 | 1019 | 0.150 |
Why?
|
Motivation | 1 | 2008 | 2025 | 0.150 |
Why?
|
Breast | 4 | 2015 | 1976 | 0.150 |
Why?
|
Sexual Behavior | 4 | 2013 | 2200 | 0.150 |
Why?
|
Vitamin D Deficiency | 3 | 2013 | 1388 | 0.140 |
Why?
|
Minority Groups | 2 | 2023 | 1216 | 0.140 |
Why?
|
Papillomavirus Infections | 1 | 2009 | 1640 | 0.140 |
Why?
|
Technetium Tc 99m Medronate | 1 | 2017 | 136 | 0.140 |
Why?
|
Attitude to Health | 3 | 2019 | 2025 | 0.140 |
Why?
|
Vaccination | 1 | 2009 | 3438 | 0.140 |
Why?
|
Proportional Hazards Models | 9 | 2019 | 12562 | 0.140 |
Why?
|
Survival Rate | 5 | 2019 | 12873 | 0.130 |
Why?
|
3-Iodobenzylguanidine | 1 | 2017 | 115 | 0.130 |
Why?
|
Communication | 1 | 2011 | 3908 | 0.130 |
Why?
|
Odds Ratio | 8 | 2014 | 9684 | 0.130 |
Why?
|
Cross-Sectional Studies | 18 | 2021 | 26395 | 0.130 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2017 | 300 | 0.130 |
Why?
|
Health Planning | 1 | 2017 | 233 | 0.130 |
Why?
|
Kidney Neoplasms | 2 | 2024 | 4300 | 0.130 |
Why?
|
Brain Neoplasms | 1 | 2017 | 9213 | 0.130 |
Why?
|
Parkinson Disease | 2 | 2022 | 2895 | 0.130 |
Why?
|
Physical Examination | 1 | 2002 | 1262 | 0.130 |
Why?
|
Premenopause | 3 | 2010 | 1039 | 0.130 |
Why?
|
Peer Group | 5 | 2007 | 698 | 0.130 |
Why?
|
Telomere | 1 | 2022 | 943 | 0.130 |
Why?
|
Human Development | 1 | 2016 | 122 | 0.130 |
Why?
|
Nuclear Medicine | 1 | 2019 | 262 | 0.120 |
Why?
|
Ascitic Fluid | 1 | 2015 | 189 | 0.120 |
Why?
|
Smoking Cessation | 5 | 2006 | 2085 | 0.120 |
Why?
|
Risk | 5 | 2017 | 9621 | 0.120 |
Why?
|
Middle Aged | 24 | 2024 | 223737 | 0.120 |
Why?
|
Follow-Up Studies | 14 | 2023 | 39394 | 0.120 |
Why?
|
Genomics | 4 | 2023 | 5928 | 0.120 |
Why?
|
Dactinomycin | 2 | 2010 | 305 | 0.120 |
Why?
|
Down Syndrome | 1 | 2023 | 919 | 0.120 |
Why?
|
Femininity | 1 | 2014 | 8 | 0.120 |
Why?
|
Masculinity | 1 | 2014 | 17 | 0.120 |
Why?
|
Drug Approval | 1 | 2021 | 821 | 0.120 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2017 | 2893 | 0.120 |
Why?
|
Lung Neoplasms | 3 | 2024 | 13594 | 0.110 |
Why?
|
Bisexuality | 2 | 2013 | 295 | 0.110 |
Why?
|
Delivery of Health Care | 3 | 2019 | 5375 | 0.110 |
Why?
|
Vaccines | 1 | 2022 | 843 | 0.110 |
Why?
|
Biomedical Research | 2 | 2021 | 3463 | 0.110 |
Why?
|
Tinnitus | 1 | 2016 | 197 | 0.110 |
Why?
|
Body Size | 1 | 2017 | 463 | 0.110 |
Why?
|
Immunologic Memory | 1 | 2021 | 1378 | 0.110 |
Why?
|
Genetic Association Studies | 3 | 2021 | 2748 | 0.110 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1794 | 0.110 |
Why?
|
Retinoblastoma | 1 | 2016 | 321 | 0.110 |
Why?
|
Multivariate Analysis | 6 | 2014 | 12095 | 0.110 |
Why?
|
Databases, Genetic | 1 | 2021 | 1758 | 0.110 |
Why?
|
Lymphoma | 1 | 2023 | 1900 | 0.110 |
Why?
|
Treatment Outcome | 11 | 2020 | 65480 | 0.110 |
Why?
|
Cyclophosphamide | 3 | 2013 | 2227 | 0.110 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2019 | 3626 | 0.110 |
Why?
|
Fertility | 2 | 2018 | 771 | 0.110 |
Why?
|
Survival Analysis | 4 | 2018 | 10115 | 0.110 |
Why?
|
Risk Assessment | 8 | 2018 | 24333 | 0.100 |
Why?
|
Weight Gain | 2 | 2017 | 2359 | 0.100 |
Why?
|
Genetic Predisposition to Disease | 5 | 2024 | 18068 | 0.100 |
Why?
|
Dietary Sucrose | 1 | 2015 | 242 | 0.100 |
Why?
|
Statistics as Topic | 3 | 2019 | 2360 | 0.100 |
Why?
|
Brazil | 1 | 2017 | 1250 | 0.100 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2015 | 329 | 0.100 |
Why?
|
Homosexuality, Female | 2 | 2012 | 171 | 0.100 |
Why?
|
Prevalence | 10 | 2023 | 15879 | 0.100 |
Why?
|
Epigenomics | 1 | 2018 | 961 | 0.100 |
Why?
|
Plant Oils | 1 | 2013 | 199 | 0.100 |
Why?
|
Biopsy | 5 | 2015 | 6805 | 0.100 |
Why?
|
Mass Screening | 3 | 2018 | 5457 | 0.100 |
Why?
|
Homosexuality | 1 | 2013 | 269 | 0.100 |
Why?
|
Suntan | 1 | 2012 | 17 | 0.100 |
Why?
|
SOS1 Protein | 1 | 2012 | 40 | 0.100 |
Why?
|
Time Factors | 7 | 2020 | 40261 | 0.100 |
Why?
|
Sarcoma | 1 | 2023 | 1806 | 0.100 |
Why?
|
Reproductive History | 1 | 2013 | 210 | 0.100 |
Why?
|
Case-Control Studies | 4 | 2023 | 22296 | 0.100 |
Why?
|
Drug Administration Schedule | 2 | 2017 | 4862 | 0.100 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2013 | 190 | 0.100 |
Why?
|
Medical Assistance | 1 | 2012 | 108 | 0.100 |
Why?
|
Nutritional Status | 2 | 2018 | 1627 | 0.100 |
Why?
|
DNA Methylation | 2 | 2018 | 4432 | 0.100 |
Why?
|
Health Services Accessibility | 4 | 2020 | 5522 | 0.100 |
Why?
|
Nerve Tissue Proteins | 2 | 2017 | 4413 | 0.100 |
Why?
|
Cytodiagnosis | 1 | 2015 | 453 | 0.100 |
Why?
|
Databases, Factual | 2 | 2024 | 8094 | 0.100 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2019 | 1376 | 0.090 |
Why?
|
Feasibility Studies | 3 | 2020 | 5323 | 0.090 |
Why?
|
Stem Cell Factor | 1 | 2011 | 194 | 0.090 |
Why?
|
Salvage Therapy | 2 | 2018 | 1277 | 0.090 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2012 | 224 | 0.090 |
Why?
|
Health Surveys | 5 | 2010 | 4055 | 0.090 |
Why?
|
Endometriosis | 1 | 2019 | 874 | 0.090 |
Why?
|
Hodgkin Disease | 1 | 2019 | 1384 | 0.090 |
Why?
|
Pregnancy | 9 | 2018 | 30265 | 0.090 |
Why?
|
Pilot Projects | 5 | 2013 | 8748 | 0.090 |
Why?
|
Analysis of Variance | 3 | 2015 | 6236 | 0.090 |
Why?
|
Neuroectodermal Tumors, Primitive | 1 | 2012 | 137 | 0.090 |
Why?
|
Morbidity | 1 | 2016 | 1757 | 0.090 |
Why?
|
Receptors, LH | 1 | 1990 | 18 | 0.090 |
Why?
|
Hematologic Neoplasms | 1 | 2023 | 1907 | 0.090 |
Why?
|
Preoperative Care | 2 | 2019 | 2258 | 0.090 |
Why?
|
Receptors, Thyrotropin | 1 | 1990 | 45 | 0.090 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2021 | 5716 | 0.090 |
Why?
|
Transients and Migrants | 1 | 2013 | 170 | 0.090 |
Why?
|
Medically Underserved Area | 1 | 2013 | 267 | 0.090 |
Why?
|
Diffusion of Innovation | 1 | 2015 | 732 | 0.090 |
Why?
|
alpha-Synuclein | 1 | 2017 | 774 | 0.090 |
Why?
|
Biopsy, Needle | 1 | 2015 | 1626 | 0.090 |
Why?
|
Motor Activity | 2 | 2013 | 2713 | 0.090 |
Why?
|
Object Attachment | 1 | 2013 | 331 | 0.090 |
Why?
|
Body Mass Index | 9 | 2018 | 13055 | 0.090 |
Why?
|
Eye Neoplasms | 1 | 2012 | 306 | 0.090 |
Why?
|
Cancer Care Facilities | 1 | 2013 | 428 | 0.080 |
Why?
|
Family Health | 2 | 2011 | 1255 | 0.080 |
Why?
|
Pedigree | 1 | 2017 | 4545 | 0.080 |
Why?
|
Cooking | 1 | 2012 | 327 | 0.080 |
Why?
|
Pinealoma | 1 | 2009 | 52 | 0.080 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3621 | 0.080 |
Why?
|
Prenatal Diagnosis | 2 | 2018 | 1275 | 0.080 |
Why?
|
Body Height | 3 | 2011 | 1569 | 0.080 |
Why?
|
Beverages | 1 | 2015 | 819 | 0.080 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3215 | 0.080 |
Why?
|
Condylomata Acuminata | 1 | 2009 | 79 | 0.080 |
Why?
|
History, 21st Century | 1 | 2015 | 1575 | 0.080 |
Why?
|
Colorectal Neoplasms | 2 | 2000 | 6982 | 0.080 |
Why?
|
Heterosexuality | 1 | 2011 | 309 | 0.080 |
Why?
|
Confidence Intervals | 3 | 2014 | 2932 | 0.080 |
Why?
|
Air Pollutants | 1 | 2023 | 2915 | 0.080 |
Why?
|
Computer Simulation | 2 | 2019 | 6291 | 0.080 |
Why?
|
Computational Biology | 1 | 2021 | 3562 | 0.080 |
Why?
|
Food Services | 1 | 2012 | 209 | 0.080 |
Why?
|
Food Preferences | 1 | 2012 | 398 | 0.080 |
Why?
|
Demography | 1 | 2013 | 1642 | 0.080 |
Why?
|
Birth Weight | 1 | 2017 | 2121 | 0.080 |
Why?
|
Bulimia | 2 | 2002 | 405 | 0.080 |
Why?
|
Age of Onset | 1 | 2015 | 3346 | 0.080 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1515 | 0.080 |
Why?
|
Aged | 12 | 2024 | 171786 | 0.070 |
Why?
|
Social Facilitation | 1 | 2007 | 31 | 0.070 |
Why?
|
Weight Loss | 1 | 1999 | 2721 | 0.070 |
Why?
|
Logistic Models | 7 | 2011 | 13318 | 0.070 |
Why?
|
Aged, 80 and over | 6 | 2024 | 59739 | 0.070 |
Why?
|
Adolescent Development | 1 | 2011 | 279 | 0.070 |
Why?
|
History, 20th Century | 1 | 2015 | 2771 | 0.070 |
Why?
|
Mass Media | 2 | 2014 | 303 | 0.070 |
Why?
|
Radiopharmaceuticals | 1 | 2017 | 2734 | 0.070 |
Why?
|
Thyroid Gland | 2 | 1991 | 1171 | 0.070 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2008 | 412 | 0.070 |
Why?
|
Pregnancy in Adolescence | 1 | 2008 | 166 | 0.070 |
Why?
|
Health Status | 2 | 2019 | 4095 | 0.070 |
Why?
|
Medically Uninsured | 1 | 2012 | 841 | 0.070 |
Why?
|
Recurrence | 1 | 2019 | 8513 | 0.070 |
Why?
|
Health Care Costs | 1 | 2020 | 3270 | 0.070 |
Why?
|
Program Development | 1 | 2013 | 1300 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2017 | 2911 | 0.070 |
Why?
|
Tobacco, Smokeless | 2 | 2014 | 133 | 0.070 |
Why?
|
Carcinoma, Basal Cell | 1 | 2012 | 565 | 0.070 |
Why?
|
Reproducibility of Results | 7 | 2018 | 20245 | 0.070 |
Why?
|
Health Status Disparities | 2 | 2016 | 1886 | 0.070 |
Why?
|
Homosexuality, Male | 2 | 2012 | 1344 | 0.070 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2007 | 211 | 0.070 |
Why?
|
Tobacco Industry | 1 | 2007 | 138 | 0.070 |
Why?
|
Vaginal Smears | 1 | 2009 | 505 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 2 | 2014 | 6547 | 0.060 |
Why?
|
Labor Unions | 1 | 2006 | 50 | 0.060 |
Why?
|
Inheritance Patterns | 2 | 2018 | 344 | 0.060 |
Why?
|
Chorionic Gonadotropin | 1 | 2008 | 458 | 0.060 |
Why?
|
Amifostine | 1 | 2005 | 40 | 0.060 |
Why?
|
Guideline Adherence | 1 | 2016 | 2241 | 0.060 |
Why?
|
RNA Splicing | 1 | 1990 | 905 | 0.060 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2007 | 416 | 0.060 |
Why?
|
Drug Residues | 1 | 2005 | 7 | 0.060 |
Why?
|
Hip Fractures | 1 | 2014 | 997 | 0.060 |
Why?
|
Radiation-Protective Agents | 1 | 2005 | 88 | 0.060 |
Why?
|
Germ Cells | 1 | 2009 | 644 | 0.060 |
Why?
|
Colonic Neoplasms | 1 | 1997 | 2543 | 0.060 |
Why?
|
Culture | 1 | 2009 | 623 | 0.060 |
Why?
|
Breast Feeding | 2 | 2006 | 1364 | 0.060 |
Why?
|
Hearing Disorders | 1 | 2005 | 126 | 0.060 |
Why?
|
China | 2 | 2021 | 2395 | 0.060 |
Why?
|
Dietary Carbohydrates | 1 | 2010 | 896 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2017 | 16053 | 0.060 |
Why?
|
Bone Neoplasms | 1 | 2017 | 2565 | 0.060 |
Why?
|
Obesity | 7 | 2016 | 13091 | 0.060 |
Why?
|
Respiratory Tract Infections | 1 | 2012 | 1014 | 0.060 |
Why?
|
Mammography | 1 | 2015 | 2434 | 0.060 |
Why?
|
Social Class | 3 | 2016 | 2009 | 0.060 |
Why?
|
T-Lymphocytes | 2 | 2022 | 10276 | 0.060 |
Why?
|
Television | 1 | 2007 | 410 | 0.060 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2007 | 631 | 0.060 |
Why?
|
Skin Pigmentation | 1 | 2006 | 281 | 0.060 |
Why?
|
Parents | 1 | 2017 | 3597 | 0.050 |
Why?
|
Butter | 1 | 2003 | 22 | 0.050 |
Why?
|
Kidney | 1 | 2019 | 7058 | 0.050 |
Why?
|
Lymph Node Excision | 2 | 2022 | 1273 | 0.050 |
Why?
|
Alaska | 1 | 2023 | 68 | 0.050 |
Why?
|
Schools | 1 | 2012 | 1498 | 0.050 |
Why?
|
Boston | 4 | 2016 | 9377 | 0.050 |
Why?
|
Food | 2 | 2000 | 768 | 0.050 |
Why?
|
Soft Tissue Neoplasms | 1 | 2012 | 1166 | 0.050 |
Why?
|
Predictive Value of Tests | 3 | 2015 | 15471 | 0.050 |
Why?
|
Residence Characteristics | 2 | 2016 | 2121 | 0.050 |
Why?
|
Tobacco Use Disorder | 2 | 2012 | 708 | 0.050 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2012 | 1335 | 0.050 |
Why?
|
Radiography | 1 | 2014 | 6991 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 3709 | 0.050 |
Why?
|
Drug Costs | 2 | 2021 | 1198 | 0.050 |
Why?
|
Parent-Child Relations | 1 | 2007 | 773 | 0.050 |
Why?
|
Human Growth Hormone | 1 | 2007 | 651 | 0.050 |
Why?
|
Benzene | 1 | 2023 | 106 | 0.050 |
Why?
|
Sex Distribution | 2 | 2014 | 2280 | 0.050 |
Why?
|
Family Characteristics | 1 | 2007 | 1004 | 0.050 |
Why?
|
Hematologic Tests | 1 | 2023 | 239 | 0.050 |
Why?
|
Radiation Protection | 1 | 2006 | 428 | 0.050 |
Why?
|
Employment | 2 | 2005 | 1114 | 0.050 |
Why?
|
Students | 1 | 2012 | 1744 | 0.050 |
Why?
|
Mutation | 3 | 2018 | 30266 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11116 | 0.050 |
Why?
|
Family | 2 | 2005 | 3208 | 0.050 |
Why?
|
Phenotype | 3 | 2021 | 16731 | 0.050 |
Why?
|
State Government | 1 | 2004 | 389 | 0.050 |
Why?
|
Cross-Over Studies | 1 | 2007 | 2108 | 0.050 |
Why?
|
Rhabdomyosarcoma | 2 | 2018 | 358 | 0.050 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2007 | 1943 | 0.040 |
Why?
|
Plants, Toxic | 1 | 2000 | 70 | 0.040 |
Why?
|
Tumor Burden | 2 | 2018 | 1913 | 0.040 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2024 | 622 | 0.040 |
Why?
|
Thyroid Neoplasms | 1 | 2014 | 2360 | 0.040 |
Why?
|
Life Tables | 1 | 2000 | 368 | 0.040 |
Why?
|
Desmoplastic Small Round Cell Tumor | 1 | 2020 | 33 | 0.040 |
Why?
|
NAD | 1 | 2024 | 618 | 0.040 |
Why?
|
RNA-Binding Proteins | 1 | 2009 | 1891 | 0.040 |
Why?
|
Biological Assay | 1 | 2023 | 628 | 0.040 |
Why?
|
Forecasting | 2 | 2021 | 2945 | 0.040 |
Why?
|
Sigmoidoscopy | 1 | 2000 | 150 | 0.040 |
Why?
|
Body Constitution | 1 | 2000 | 273 | 0.040 |
Why?
|
Nerve Degeneration | 1 | 2024 | 750 | 0.040 |
Why?
|
Thailand | 1 | 2020 | 288 | 0.040 |
Why?
|
Occupational Health | 2 | 2003 | 812 | 0.040 |
Why?
|
Occult Blood | 1 | 2000 | 199 | 0.040 |
Why?
|
Africa | 1 | 2022 | 726 | 0.040 |
Why?
|
Acne Vulgaris | 1 | 2005 | 352 | 0.040 |
Why?
|
Animals | 12 | 2018 | 169335 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2021 | 640 | 0.040 |
Why?
|
Child Abuse | 1 | 2008 | 1091 | 0.040 |
Why?
|
Health Education | 2 | 2003 | 1059 | 0.040 |
Why?
|
Self-Assessment | 1 | 2001 | 400 | 0.040 |
Why?
|
Self Efficacy | 1 | 2003 | 643 | 0.040 |
Why?
|
Linear Models | 4 | 2004 | 5891 | 0.040 |
Why?
|
Cranial Irradiation | 1 | 2021 | 395 | 0.040 |
Why?
|
Decision Trees | 1 | 2020 | 509 | 0.040 |
Why?
|
Computer Security | 1 | 2021 | 260 | 0.040 |
Why?
|
Amino Acid Sequence | 4 | 2017 | 13427 | 0.040 |
Why?
|
Diet Surveys | 2 | 2005 | 1160 | 0.040 |
Why?
|
Eating | 1 | 2005 | 1542 | 0.040 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2018 | 89 | 0.040 |
Why?
|
Preoperative Period | 1 | 2020 | 565 | 0.040 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2007 | 2056 | 0.040 |
Why?
|
Focus Groups | 1 | 2004 | 1462 | 0.040 |
Why?
|
Substance-Related Disorders | 2 | 2016 | 4423 | 0.040 |
Why?
|
Ifosfamide | 1 | 2018 | 233 | 0.040 |
Why?
|
Sexually Transmitted Diseases | 2 | 2016 | 668 | 0.040 |
Why?
|
Psychometrics | 2 | 2004 | 3066 | 0.040 |
Why?
|
DNA | 2 | 1991 | 7214 | 0.040 |
Why?
|
Population Surveillance | 2 | 2019 | 2597 | 0.040 |
Why?
|
Ecosystem | 1 | 2021 | 494 | 0.030 |
Why?
|
Testis | 1 | 2020 | 784 | 0.030 |
Why?
|
Disease Management | 2 | 2018 | 2537 | 0.030 |
Why?
|
Markov Chains | 1 | 2000 | 979 | 0.030 |
Why?
|
Models, Psychological | 2 | 2013 | 826 | 0.030 |
Why?
|
Axons | 1 | 2024 | 1678 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2012 | 4064 | 0.030 |
Why?
|
Watchful Waiting | 1 | 2020 | 498 | 0.030 |
Why?
|
South Africa | 1 | 2021 | 1872 | 0.030 |
Why?
|
Penetrance | 1 | 2018 | 386 | 0.030 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2008 | 2542 | 0.030 |
Why?
|
Health Status Indicators | 1 | 2001 | 971 | 0.030 |
Why?
|
Nervous System | 1 | 2019 | 546 | 0.030 |
Why?
|
Cryopreservation | 1 | 2021 | 734 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1855 | 0.030 |
Why?
|
Colonic Polyps | 1 | 2000 | 557 | 0.030 |
Why?
|
Iodine Radioisotopes | 2 | 2017 | 1034 | 0.030 |
Why?
|
Disease Progression | 1 | 2013 | 13674 | 0.030 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2018 | 260 | 0.030 |
Why?
|
Healthcare Disparities | 1 | 2011 | 3421 | 0.030 |
Why?
|
Multiple Sclerosis | 1 | 2010 | 3250 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2018 | 948 | 0.030 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2018 | 249 | 0.030 |
Why?
|
Cholesterol, Dietary | 1 | 1995 | 224 | 0.030 |
Why?
|
Ovarian Diseases | 1 | 2016 | 137 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2020 | 1669 | 0.030 |
Why?
|
Sports | 1 | 2001 | 703 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2010 | 14752 | 0.030 |
Why?
|
Social Support | 2 | 2003 | 2193 | 0.030 |
Why?
|
Occupations | 1 | 1997 | 516 | 0.030 |
Why?
|
Behavior | 1 | 2018 | 543 | 0.030 |
Why?
|
Area Under Curve | 1 | 2019 | 1645 | 0.030 |
Why?
|
Dietary Proteins | 2 | 2000 | 960 | 0.030 |
Why?
|
Tanning | 1 | 2014 | 12 | 0.030 |
Why?
|
Health Resources | 1 | 2021 | 951 | 0.030 |
Why?
|
Overweight | 1 | 2006 | 2448 | 0.030 |
Why?
|
Pathology, Surgical | 1 | 2015 | 150 | 0.030 |
Why?
|
Self Concept | 1 | 2000 | 1046 | 0.030 |
Why?
|
Deafness | 1 | 2018 | 462 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2021 | 1406 | 0.030 |
Why?
|
Transplantation Conditioning | 1 | 2021 | 1601 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2015 | 508 | 0.030 |
Why?
|
Dehydrocholesterols | 1 | 2013 | 20 | 0.030 |
Why?
|
Mosaicism | 1 | 2017 | 481 | 0.030 |
Why?
|
Unsafe Sex | 1 | 2016 | 239 | 0.030 |
Why?
|
Leukocytes | 1 | 2022 | 2034 | 0.030 |
Why?
|
Interpersonal Relations | 1 | 2001 | 1437 | 0.030 |
Why?
|
Homozygote | 1 | 2018 | 1780 | 0.030 |
Why?
|
Carbonated Beverages | 1 | 2015 | 210 | 0.030 |
Why?
|
Life Expectancy | 1 | 2000 | 1249 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 1839 | 0.030 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2017 | 827 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2012 | 1769 | 0.030 |
Why?
|
Depression | 1 | 2013 | 8231 | 0.030 |
Why?
|
Methionine | 1 | 1995 | 573 | 0.030 |
Why?
|
Mice, SCID | 1 | 2018 | 2631 | 0.030 |
Why?
|
Drinking | 1 | 2014 | 196 | 0.030 |
Why?
|
Genome | 1 | 2021 | 1754 | 0.030 |
Why?
|
Colonoscopy | 1 | 2000 | 1410 | 0.030 |
Why?
|
Sweetening Agents | 1 | 2015 | 290 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 1990 | 11932 | 0.030 |
Why?
|
Massachusetts | 4 | 2008 | 8894 | 0.030 |
Why?
|
Ascorbic Acid | 1 | 1995 | 658 | 0.020 |
Why?
|
Nutrition Assessment | 1 | 1995 | 740 | 0.020 |
Why?
|
Health Policy | 1 | 2004 | 2700 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 2018 | 1780 | 0.020 |
Why?
|
Leukemia, T-Cell | 1 | 1992 | 102 | 0.020 |
Why?
|
Topotecan | 1 | 2012 | 131 | 0.020 |
Why?
|
HLA Antigens | 1 | 2017 | 1336 | 0.020 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2017 | 977 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2009 | 11684 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2011 | 6086 | 0.020 |
Why?
|
Qualitative Research | 1 | 2023 | 3143 | 0.020 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 1992 | 286 | 0.020 |
Why?
|
Molecular Typing | 1 | 2011 | 115 | 0.020 |
Why?
|
Necrosis | 1 | 2015 | 1620 | 0.020 |
Why?
|
Taste | 1 | 2012 | 190 | 0.020 |
Why?
|
Sirolimus | 1 | 2018 | 1540 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 2009 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2019 | 2360 | 0.020 |
Why?
|
Genotype | 2 | 2018 | 13048 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2016 | 13021 | 0.020 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 1992 | 453 | 0.020 |
Why?
|
Parity | 1 | 2013 | 931 | 0.020 |
Why?
|
Receptors, Adrenergic, beta | 1 | 1991 | 243 | 0.020 |
Why?
|
Molecular Sequence Data | 3 | 2012 | 17629 | 0.020 |
Why?
|
Patient Compliance | 1 | 2000 | 2701 | 0.020 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2017 | 1803 | 0.020 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2012 | 877 | 0.020 |
Why?
|
Cost of Illness | 1 | 2020 | 1960 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2019 | 2228 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2015 | 1793 | 0.020 |
Why?
|
Mexico | 1 | 2012 | 769 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 1992 | 354 | 0.020 |
Why?
|
Reproductive Medicine | 1 | 2011 | 99 | 0.020 |
Why?
|
Ribonucleases | 1 | 1990 | 266 | 0.020 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 2009 | 83 | 0.020 |
Why?
|
Maternal Exposure | 1 | 2017 | 1095 | 0.020 |
Why?
|
Autoimmunity | 1 | 2017 | 1360 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1990 | 1057 | 0.020 |
Why?
|
Nutritive Value | 1 | 2012 | 351 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2014 | 1194 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2020 | 2909 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 1990 | 1305 | 0.020 |
Why?
|
Folic Acid | 1 | 1995 | 1338 | 0.020 |
Why?
|
Alcoholic Beverages | 1 | 2010 | 266 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 4413 | 0.020 |
Why?
|
Introns | 1 | 1990 | 969 | 0.020 |
Why?
|
Algorithms | 2 | 2019 | 14201 | 0.020 |
Why?
|
Calcium, Dietary | 1 | 2010 | 533 | 0.020 |
Why?
|
Puberty | 1 | 2011 | 501 | 0.020 |
Why?
|
Cytokines | 1 | 2022 | 7453 | 0.020 |
Why?
|
Seasons | 1 | 2013 | 1524 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2000 | 5544 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2021 | 4794 | 0.020 |
Why?
|
Mortality | 1 | 2019 | 2914 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2012 | 1246 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2012 | 1836 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2018 | 5801 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4651 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2023 | 5707 | 0.020 |
Why?
|
Social Values | 1 | 2008 | 224 | 0.020 |
Why?
|
Adiposity | 1 | 2017 | 1895 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2016 | 1876 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 1992 | 1395 | 0.020 |
Why?
|
Trauma Severity Indices | 1 | 2008 | 479 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10592 | 0.020 |
Why?
|
Alleles | 1 | 2017 | 6901 | 0.020 |
Why?
|
Choice Behavior | 1 | 2012 | 848 | 0.020 |
Why?
|
Transgenes | 1 | 2009 | 1016 | 0.020 |
Why?
|
Face | 1 | 2012 | 1031 | 0.020 |
Why?
|
Terminal Care | 1 | 2018 | 1772 | 0.020 |
Why?
|
Doxorubicin | 1 | 2012 | 2234 | 0.020 |
Why?
|
Vitamins | 1 | 2013 | 1638 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3836 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 1990 | 4168 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2017 | 5151 | 0.010 |
Why?
|
Poverty | 1 | 2016 | 2720 | 0.010 |
Why?
|
Genetic Testing | 1 | 2018 | 3591 | 0.010 |
Why?
|
Social Marketing | 1 | 2004 | 52 | 0.010 |
Why?
|
Mental Health | 1 | 2019 | 3275 | 0.010 |
Why?
|
Exons | 1 | 1990 | 2395 | 0.010 |
Why?
|
Persuasive Communication | 1 | 2004 | 58 | 0.010 |
Why?
|
Research | 1 | 2012 | 1981 | 0.010 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2009 | 724 | 0.010 |
Why?
|
Contrast Media | 1 | 2017 | 5334 | 0.010 |
Why?
|
Women's Health | 1 | 2013 | 2081 | 0.010 |
Why?
|
Food Contamination | 1 | 2005 | 193 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2015 | 3205 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8749 | 0.010 |
Why?
|
Killer Cells, Natural | 1 | 1992 | 2211 | 0.010 |
Why?
|
Palliative Care | 1 | 2018 | 3644 | 0.010 |
Why?
|
Cell Cycle | 1 | 1991 | 2937 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 14484 | 0.010 |
Why?
|
Prescription Drugs | 1 | 2010 | 635 | 0.010 |
Why?
|
Embryonic Stem Cells | 1 | 2009 | 1251 | 0.010 |
Why?
|
Electrocardiography | 1 | 2015 | 6413 | 0.010 |
Why?
|
Acute Disease | 1 | 2012 | 7245 | 0.010 |
Why?
|
Cell Line | 3 | 2009 | 15604 | 0.010 |
Why?
|
Siblings | 1 | 2006 | 828 | 0.010 |
Why?
|
Research Design | 1 | 1997 | 6214 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 13510 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2018 | 17173 | 0.010 |
Why?
|
Hormones | 1 | 2005 | 870 | 0.010 |
Why?
|
Transcription Factors | 2 | 2011 | 12174 | 0.010 |
Why?
|
Health Personnel | 1 | 2014 | 3383 | 0.010 |
Why?
|
Signal Transduction | 3 | 2012 | 23653 | 0.010 |
Why?
|
Radiotherapy | 1 | 2007 | 1506 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2015 | 4530 | 0.010 |
Why?
|
Base Sequence | 1 | 1990 | 12430 | 0.010 |
Why?
|
Cattle | 1 | 2005 | 3819 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 2862 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2013 | 3238 | 0.010 |
Why?
|
Social Environment | 1 | 2003 | 1015 | 0.010 |
Why?
|
Fathers | 1 | 2001 | 377 | 0.010 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2001 | 352 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 1991 | 4528 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2009 | 2986 | 0.010 |
Why?
|
Commerce | 1 | 2003 | 613 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2012 | 12467 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2017 | 12801 | 0.010 |
Why?
|
Bone Marrow | 1 | 2007 | 2936 | 0.010 |
Why?
|
Labor, Obstetric | 1 | 1999 | 323 | 0.010 |
Why?
|
Dietary Fiber | 1 | 2000 | 767 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 1995 | 18354 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2005 | 2649 | 0.010 |
Why?
|
Educational Status | 1 | 2001 | 2515 | 0.010 |
Why?
|
Nutrition Surveys | 1 | 2001 | 1738 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2009 | 8664 | 0.010 |
Why?
|
Regression Analysis | 1 | 2001 | 6346 | 0.010 |
Why?
|
DNA, Antisense | 1 | 1991 | 44 | 0.010 |
Why?
|
Oncogene Protein pp60(v-src) | 1 | 1991 | 75 | 0.010 |
Why?
|
Thymidine | 1 | 1991 | 297 | 0.010 |
Why?
|
Genes, myc | 1 | 1992 | 391 | 0.010 |
Why?
|
Isoproterenol | 1 | 1991 | 398 | 0.010 |
Why?
|
Retroviridae Infections | 1 | 1991 | 148 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2009 | 22379 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20776 | 0.010 |
Why?
|
Interphase | 1 | 1991 | 227 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 1991 | 205 | 0.010 |
Why?
|
Postmenopause | 1 | 1999 | 2519 | 0.010 |
Why?
|
Depressive Disorder | 1 | 2001 | 3723 | 0.000 |
Why?
|
Thyrotropin | 1 | 1991 | 834 | 0.000 |
Why?
|
Cyclic AMP | 1 | 1991 | 1469 | 0.000 |
Why?
|
Energy Metabolism | 1 | 1997 | 2905 | 0.000 |
Why?
|
Enzyme Activation | 1 | 1991 | 3588 | 0.000 |
Why?
|
Protein Kinases | 1 | 1991 | 1611 | 0.000 |
Why?
|
Cell Division | 1 | 1991 | 4478 | 0.000 |
Why?
|
Mice | 1 | 2009 | 82072 | 0.000 |
Why?
|
Antigens, CD | 1 | 1992 | 4032 | 0.000 |
Why?
|
Phosphorylation | 1 | 1991 | 8317 | 0.000 |
Why?
|
Models, Biological | 1 | 1991 | 9499 | 0.000 |
Why?
|